Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity.
Journal: Angewandte Chemie (International ed. in English)
Published: November 14, 2025
Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers.
Journal: The Journal of clinical investigation
Published: October 31, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026